The FDA has granted Fast Track designation to the investigational antibody-drug conjugate (ADC) SIM0505 for the treatment of women with platinum-resistant ovarian cancer. The designation adds SIM0505 ...

The FDA has granted fast track and rolling review status to Celltrion’s CT-P71, a Nectin-4 targeting ADC for treating ...

Discover how OS Therapies' immunotherapy, OST-HER2, originally developed for canine osteosarcoma, shows promising results in fast-tracking treatments for human osteosarcoma. Learn about comparative ...

CTIM-76 has received FDA fast track designation for platinum-resistant ovarian cancer, a step aimed at accelerating ...

Iovance Biotherapeutics (IOVA) has become a focus for investors after new data for its Amtagvi therapy showed strong response and disease control rates in advanced melanoma and sarcoma, alongside ...

Basal cell carcinoma grows at about 0.7 millimeters per month on average. Melanoma can spread quickly, but growth rates vary by type and location. Checking skin regularly can help detect skin cancer ...

A cancer diagnosis is never welcome news. But for certain types of cancers, a doctor’s confirmation can be a lifesaver. That’s especially true with colorectal—or colon—cancer (CRC): When caught early, ...